What is the optimal intrathecal chemotherapy regimen for leptomeningeal carcinomatosis from breast cancer?

For HER2- disease, we tend to do IT methotrexate or topotecan. For HER2+ disease, we routinely do IT Herceptin plus systemic treatments with a TKI like lapatinib with excellent long term control in some patients.